The History of Alzheimer's
Disease
Alzheimer's disease is a terrible
problem that has been affecting those old in age for centuries.
Most of the knowledge that we have about the affliction, we've
learned within the past one hundred years. In this article,
we'll give you a brief history of our knowledge of the disease,
letting you know where our basic understandings of the disease
came from and some of the advances that are being made
today.
Alzheimer's disease was first discovered by a German doctor
named Alois Alzheimer. The doctor discovered the disease when
he was performing an autopsy on a woman who died of a
mysterious, unknown form of mental illness. When Alzheimer
studied the brain of the woman, he was shocked to find the
presence of abnormal lumps of plaque and twisted fibers present
in her brain that were unlike anything he'd ever seen before.
These two odd parts of the woman's anatomy proved to be the
basis for Alzheimer's disease, with the lumps becoming known as
neuritic plaques and the fibers being called neurofibrillary
tangles. To this day, the presence of these lumps and fibers
are the way that doctors can confirm the presence of
Alzheimer's disease. Unfortunately, these symptoms can only be
seen via an autopsy performed after a patient's death.
One discovery that changed our knowledge of Alzheimer's
disease is when Familial Alzheimer's disease was discovered.
This subset of the disease occurs in approximately 10 percent
of all patients with Alzheimer's, and it is a particularly
aggressive form of the disease. It occurs early in almost every
case, with most becoming afflicted with the disease before the
age of 65. One of the most unfortunate aspects of Familial
Alzheimer's disease is the fact that it can be passed down
genetically from parent to child. If one parent has Familial
Alzheimer's, the child's risk of getting the disease rests at
an even 50-50. Familial Alzheimer's is the only type of the
disease that can be traced to a genetic abnormality; late-onset
Alzheimer's may appear randomly and without just cause.
1993 saw one of the first significant developments in
fighting Alzheimer's disease. In this year, the Food and Drug
Administration of the United States of America gave approval to
the first drug designed to help Alzheimer's patients. Known as
Cognex, the pill worked to increase the amount of acetylcholine
in the brain, which is a neurotransmitter that can help to slow
the mind-damaging aspects of the disease. Within the next few
years, 3 more drugs came out in order to increase acetylcholine
levels in Alzheimer's patients. In 1997, scientists discovered
that the use of Vitamin E and a Parkinson's disease drug known
as Eldepryl were shown to be effective in slowing the mental
decline of Alzheimer's patients, offering another solution when
it comes to slowing the disease. The latest advancement came in
2003 when the FDA approved a radically different drug that is
known as Namenda. It is used in order to protect the brain
cells of an Alzheimer's patient by blocking the amount of
Glutamine that is present in the brain, which can damage the
cells.
More and more research is being conducted when it comes to
finding possible solutions for those with Alzheimer's, and
hopefully, the advancements that are being made will continue
to help those with this devastating
disease.
|